Literature DB >> 6305265

Comparative in vitro susceptibilities of anaerobic bacteria to cefmenoxime, cefotetan, and N-formimidoyl thienamycin.

W E Owens, S M Finegold.   

Abstract

The in vitro activities of cefmenoxime, cefotetan, and N-formimidoyl thienamycin were compared with those of other antimicrobial agents (metronidazole, clindamycin, cefoxitin, and moxalactam) against anaerobic bacteria. The data obtained indicate that N-formimidoyl thienamycin exhibits excellent activity against anaerobic bacteria; cefotetan and cefmenoxime, though less active, should be of value in treating selected anaerobic infections.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6305265      PMCID: PMC184715          DOI: 10.1128/AAC.23.4.626

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  7 in total

1.  Antimicrobial therapy of anaerobic infections: a status report.

Authors:  S M Finegold
Journal:  Hosp Pract       Date:  1979-10

2.  Comparative in vitro activity of ceftriaxone against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1982-08       Impact factor: 5.191

3.  Susceptibility of anaerobic bacteria to 23 antimicrobial agents.

Authors:  V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1976-10       Impact factor: 5.191

4.  Comparative in vitro activity of 1-oxa-beta-lactam (LY127935) and cefoperazone with other beta-lactam antibiotics against anaerobic bacteria.

Authors:  M V Borobio; J Aznar; R Jimenez; F Garcia; E J Perea
Journal:  Antimicrob Agents Chemother       Date:  1980-02       Impact factor: 5.191

5.  Comparative in vitro activity of new beta-lactam antibiotics against anaerobic bacteria.

Authors:  R D Rolfe; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1981-11       Impact factor: 5.191

Review 6.  Gram-negative anaerobic bacilli: their role in infection and patterns of susceptibility to antimicrobial agents. I. Little-known Bacteroides species.

Authors:  B D Kirby; W L George; V L Sutter; D M Citron; S M Finegold
Journal:  Rev Infect Dis       Date:  1980 Nov-Dec

7.  Comparative susceptibilities of anaerobic bacteria to metronidazole, ornidazole, and SC-28538.

Authors:  E J Goldstein; V L Sutter; S M Finegold
Journal:  Antimicrob Agents Chemother       Date:  1978-10       Impact factor: 5.191

  7 in total
  13 in total

1.  Susceptibilities of Bacteroides and Fusobacterium spp. from foot rot in goats to 10 beta-lactam antibiotics.

Authors:  S Piriz Duran; J Valle Manzano; R Cuenca Valera; S Vadillo Machota
Journal:  Antimicrob Agents Chemother       Date:  1990-04       Impact factor: 5.191

Review 2.  In vitro antibacterial effects of cephalosporins.

Authors:  J D Williams; F Moosdeen
Journal:  Drugs       Date:  1987       Impact factor: 9.546

3.  In vitro activity of imipenem against anaerobic bacteria.

Authors:  D Megran; C Carlson; A Chow
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

Review 4.  In vitro activity of imipenem--a review.

Authors:  I Braveny
Journal:  Eur J Clin Microbiol       Date:  1984-10       Impact factor: 3.267

5.  In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.

Authors:  S D Shafran; J Wong; A W Chow
Journal:  Antimicrob Agents Chemother       Date:  1985-05       Impact factor: 5.191

6.  Cefmenoxime therapy of serious bacterial infections.

Authors:  M E Gombert; L A Glasser; R H Eng
Journal:  Antimicrob Agents Chemother       Date:  1984-04       Impact factor: 5.191

Review 7.  Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  S P Clissold; P A Todd; D M Campoli-Richards
Journal:  Drugs       Date:  1987-03       Impact factor: 9.546

Review 8.  Cefotetan. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  A Ward; D M Richards
Journal:  Drugs       Date:  1985-11       Impact factor: 9.546

Review 9.  Cefmenoxime. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use.

Authors:  D M Campoli-Richards; P A Todd
Journal:  Drugs       Date:  1987-08       Impact factor: 9.546

10.  Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1985-02       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.